SUMMARY Parkinson's disease is the second most common neurodegenerative disease, with an estimated prevalence of 41/100,000 individuals affected aged between 40 and 49 years old and 1,900/100,000 aged 80 and over. Based on the essentiality of ascertaining which wearable devices have clinical literary evidence and with the purpose of analyzing the information revealed by such technologies, we conducted this scientific article of integrative review. It is an integrative review, whose main objective is to carry out a summary of the state of the art of wearable devices used in patients with Parkinson's disease. After the review, we retrieved 8 papers. Of the selected articles, only 3 were not systematic reviews; one was a series of cases and two prospective longitudinal studies. These technologies have a very rich field of application; however, research is still necessary to make such evaluations reliable and crucial to the well-being of these patients.

O objetivo deste trabalho é relatar a experiência de discentes do curso de Medicina da Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM) em um projeto de intervenção que visou capacitar os Agentes Comunitários de Saúde (ACS) de uma Estratégia de Saúde da Família do município de Diamantina/MG. O projeto foi desenvolvido entre os meses de abril e julho de 2016 por oito discentes e uma docente do curso de Medicina da UFVJM. Foram realizados 10 encontros semanais com duração de 2 horas cada, cujo foco foi a capacitação dos ACS de temas escolhidos mediante prevalência de doenças da área de atuação da equipe de saúde. É de extrema importância a educação permanente em saúde dos ACS, quetem como objetivo influenciar positivamente nos indicadores de saúde da comunidade por meio de uma construção mais eficaz do conhecimento técnico-científico-reflexivo inerente ao dia a dia do profissional de saúde.

No abstract

Stroke management and quality of care in low and middle-income countries: an integrative literature review Manejo do AVC e qualidade da assistência em países de baixa e média renda: uma revisão integrativa da literatura

Staphylococcus aureus (S.aureus) infections with Vancomycin resistance in hospital complexes are a concern, a significant increase in the number of these occurrences is observed since it is one of the last available antibiotic therapy routes available for the treatment of infectious processes bacterium. Thus, this work aims to present the main mechanism of resistance induction of S. aureus to Vancomycin. The research used the databases Medline, Scielo, the electronic site of the Google Scholar databases as well as specialized magazines in the area. Thus, the selected articles showed that in the late 1950s almost half of S. aureus strains were resistant to penicillin, and in the 1970s the first cases of methicillin-resistant S. aureus (MRSA) appeared; and thus, Vancomycin became employed in such cases. In 1996, the first case of S. aureus with intermediate resistance to vancomycin (VISA) was found. In 2002, the first case of Vancomycin-resistant S. aureus (VRSA) occurred, the latter being the only known to have the VanA gene until then. It was soon discovered that the emergence of this resistance occurred from the transfer of a plasmid with the transposon of the vancomycin resistant vanA, Tn1546 vancomycin (VRE) gene to an MRSA, which already had a plasmid for resistance to gentamicin and production of beta-lactamase. This new plasmid was disseminated to other S. aureus and thus disseminating a new resistance. Thus, the conclusion is that the cycle repeats itself and previously sensitive bacteria become resistant; thus, in this rhythm of emergence of bacterial resistance against antibiotic therapy is worrying, there will be a moment when there will be no antibiotic capable of acting in the fight against bacteria. This shows the need to understand the mechanism of resistance, the discovery of new antimicrobial drugs and the prevention of the spread of resistant microbes.Key words: Staphylococcus aureus, vancomycin, microbial drug resistance, vancomycin resistance.